6.69
price up icon0.90%   0.06
after-market Handel nachbörslich: 6.63 -0.06 -0.90%
loading
Schlusskurs vom Vortag:
$6.63
Offen:
$6.7
24-Stunden-Volumen:
112.66K
Relative Volume:
1.22
Marktkapitalisierung:
$72.44M
Einnahmen:
$1.93M
Nettoeinkommen (Verlust:
$-7.96M
KGV:
-0.00189
EPS:
-3530.8178
Netto-Cashflow:
$-36.78M
1W Leistung:
+7.04%
1M Leistung:
+39.67%
6M Leistung:
-11.27%
1J Leistung:
-42.53%
1-Tages-Spanne:
Value
$6.3551
$6.75
1-Wochen-Bereich:
Value
$6.345
$7.15
52-Wochen-Spanne:
Value
$3.39
$16.00

Avalo Therapeutics Inc Stock (AVTX) Company Profile

Name
Firmenname
Avalo Therapeutics Inc
Name
Telefon
410-522-8707
Name
Adresse
1500 LIBERTY RIDGE DRIVE, WAYNE
Name
Mitarbeiter
23
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
AVTX's Discussions on Twitter

Vergleichen Sie AVTX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AVTX
Avalo Therapeutics Inc
6.69 71.79M 1.93M -7.96M -36.78M -3,530.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-02 Fortgesetzt H.C. Wainwright Buy
2025-03-25 Eingeleitet Jefferies Buy
2025-03-25 Eingeleitet Stifel Buy
2025-02-28 Eingeleitet Piper Sandler Overweight
2025-02-21 Eingeleitet Wedbush Outperform
2024-12-19 Eingeleitet BTIG Research Buy
2024-10-24 Eingeleitet H.C. Wainwright Neutral
2024-04-16 Hochstufung Oppenheimer Perform → Outperform
2021-09-24 Eingeleitet RBC Capital Mkts Outperform
Alle ansehen

Avalo Therapeutics Inc Aktie (AVTX) Neueste Nachrichten

pulisher
Jul 25, 2025

What drives Avalo Therapeutics Inc. stock priceHigh-yield investments - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Avalo Therapeutics Inc. Stock Analysis and ForecastAccelerated capital growth - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

When is the best time to buy Avalo Therapeutics Inc. stockExponentially increasing returns - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about Avalo Therapeutics Inc. stockUnmatched market gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Avalo Therapeutics Inc. a good long term investmentUnmatched market performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target By Investing.com - Investing.com South Africa

Jul 22, 2025
pulisher
Jul 22, 2025

Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target - Investing.com Australia

Jul 22, 2025
pulisher
Jul 21, 2025

Avalo Therapeutics Soars 10.66% on Bullish Sentiment - AInvest

Jul 21, 2025
pulisher
Jul 18, 2025

Avalo Therapeutics (AVTX) Soars 10.42% on Analyst Upgrade - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

What makes Avalo Therapeutics Inc. stock attractive to long term investorsBalanced Risk Reward Portfolio - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

What institutions are buying Avalo Therapeutics Inc. stock nowGrowth Optimized Stock Radar - beatles.ru

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Avalo Therapeutics Inc. stock price move sharplyBreakout Confirmation Tool - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Avalo Therapeutics Inc. stock attracts strong analyst attentionIntraday Trade Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Avalo Therapeutics Inc. stock performs during market volatilityVolume Spike Monitors - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

(AVTX) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 09, 2025
pulisher
Jul 04, 2025

Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Jul 03, 2025
pulisher
Jun 29, 2025

How To Trade (AVTX) - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 26, 2025

15 Best Growth Stocks to Invest in for the Next 5 Years - Insider Monkey

Jun 26, 2025
pulisher
Jun 23, 2025

Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Jun 23, 2025
pulisher
Jun 20, 2025

Avalo Therapeutics Highlights Potential of AVTX-009 in HS - TipRanks

Jun 20, 2025
pulisher
Jun 18, 2025

(AVTX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics appoints Dr. Rita Jain to board of directors By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics (AVTX) Welcomes New Board Member | AVTX Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors - GlobeNewswire

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to B - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Avalo Therapeutics appoints Dr. Rita Jain to board of directors - Investing.com

Jun 18, 2025

Finanzdaten der Avalo Therapeutics Inc-Aktie (AVTX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Kapitalisierung:     |  Volumen (24h):